Takahashi et al. (2009) proposed an opposing role of MCP-1, concluding that MCP-1 negatively regulates breast cancer metastasis to the bone and lung, and associated MCP-1 inhibition with a greater incidence of breast cancer bone and lung metastasis in their murine model [81]. This evidence concerns the gene CCL2 and breast carcinoma.